Liver fibrosis markers of nonalcoholic steatohepatitis

Glycated albumin; clinical usefulness

(2014) Masafumi Koga   CLINICA CHIMICA ACTA

Current status of fibrosis markers

(2014) Keyur Patel et al.   CURRENT OPINION IN GASTROENTEROLOGY

A novel serum marker, glycosylated Wisteria floribunda agglutinin-positive Mac-2 binding protein (WFA+-M2BP), for assessing liver fibrosis

(2014) Takeo Toshima et al.   JOURNAL OF GASTROENTEROLOGY

Noninvasive biomarkers in non-alcoholic fatty liver disease: Current status and a glimpse of the future

(2014) Emer Fitzpatrick   WORLD JOURNAL OF GASTROENTEROLOGY

An Increased Ratio of Glycated Albumin to HbA1c Is Associated with the Degree of Liver Fibrosis in Hepatitis B Virus-Positive Patients

(2014) Hirayuki Enomoto et al.   Gastroenterology Research and Practice

From NAFLD in clinical practice to answers from guidelines

(2013) Fabio Nascimbeni et al.   JOURNAL OF HEPATOLOGY

A serum “sweet-doughnut” protein facilitates fibrosis evaluation and therapy assessment in patients with viral hepatitis

(2013) Atsushi Kuno et al.   Scientific Reports

LecT-hepa, a glyco-marker derived from multiple lectins, as a predictor of liver fibrosis in chronic hepatitis C patients

(2012) Kiyoaki Ito et al.   HEPATOLOGY

The glycated albumin to glycated haemoglobin ratio increases along with the fibrosis stage in non-alcoholic steatohepatitis

(2012) Y. Bando et al.   ANNALS OF CLINICAL BIOCHEMISTRY

Platelet count for predicting fibrosis in nonalcoholic fatty liver disease

(2011) Masato Yoneda et al.   JOURNAL OF GASTROENTEROLOGY

Glycation research in amino acids: a place to call home

(2010) Naila Rabbani et al.   AMINO ACIDS

Enhanced liver fibrosis test can predict clinical outcomes in patients with chronic liver disease

(2010) J. Parkes et al.   GUT

Noninvasive assessment of liver fibrosis

(2010) Stella M. Martínez et al.   HEPATOLOGY

A simple clinical scoring system using ferritin, fasting insulin, and type IV collagen 7S for predicting steatohepatitis in nonalcoholic fatty liver disease

(2010) Yoshio Sumida et al.   JOURNAL OF GASTROENTEROLOGY

A Biomarker Panel for Non-alcoholic Steatohepatitis (NASH) and NASH-Related Fibrosis

(2010) Zobair M. Younossi et al.   OBESITY SURGERY

Comparison of Noninvasive Markers of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease

(2009) Amy G. Shah et al.   Clinical Gastroenterology and Hepatology

GlycoFibroTest Is a Highly Performant Liver Fibrosis Biomarker Derived from DNA Sequencer-based Serum Protein Glycomics

(2009) Dieter Vanderschaeghe et al.   MOLECULAR & CELLULAR PROTEOMICS

Liver Fibrosis in Viral Hepatitis: Noninvasive Assessment with Acoustic Radiation Force Impulse Imaging versus Transient Elastography

(2009) Mireen Friedrich-Rust et al.   RADIOLOGY

Association of serum glycated albumin to haemoglobin A1C ratio with hepatic function tests in patients with chronic liver disease

(2009) Y. Bando et al.   ANNALS OF CLINICAL BIOCHEMISTRY

CLD (chronic liver diseases)-HbA1C as a suitable indicator for estimation of mean plasma glucose in patients with chronic liver diseases

(2008) Masafumi Koga et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease

(2008) S A Harrison et al.   GUT

Liver biopsy

(2008) Don C. Rockey et al.   HEPATOLOGY

Comparison of blood tests for liver fibrosis specific or not to NAFLD

(2008) Paul Calès et al.   JOURNAL OF HEPATOLOGY